Magnetic resonance imaging detected additional cancers among women who underwent breast conservation therapy following early diagnosis of breast cancer.
Single-screening MRI found additional cancers among women with a history of breast conservation therapy (BCT), according to a study published in the journal Radiology.
Korean researchers undertook a retrospective study to determine the outcomes of single-screening breast MRI in women who had a history of BCT for breast cancers.
The study group comprised 607 women (median age 48 years) who underwent BCT for breast cancer, had negative mammography and US findings, and underwent subsequent screening breast MR imaging. A total of 557 women (91.8 percent) underwent preoperative MR examinations. The researchers assessed cancer detection rate, characteristics of detected cancers, positive predictive value (PPV), sensitivity, and specificity.
Results showed additional findings by MRI of 11 cancers (eight invasive, three ductal carcinoma in situ) for 18.1 cancers per 1,000 women. The median invasive size was 0.8 cm (range, 0.4–1.4 cm). All were node negative. PPV for recall was 9.4 percent (11 of 117 examinations; PPV for biopsy: 43.5 percent (10 of 23 examinations); sensitivity: 91.7 percent (11 of 12 examinations); and specificity: 82.2 percent (489 of 595 examinations).
“At multivariate analysis, the independent factors associated with women with MR-detected cancers were age younger than 50 years at initial diagnosis and more than a 24-month interval between initial surgery and screening MR imaging,” the authors wrote.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.